Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

5040results about How to "Reduced response" patented technology

Method and apparatus for predicting the risk of hypoglycemia

The invention relates to a method which utilizes blood glucose (“BG”) sampling, insulin infusion / injection records, heart rate (“HR”) information and heart rate varability (“HRV”) information to estimate BG in the near future and to estimate of the risk of the onset of hypoglycemia. The invention also relates to an apparatus for predicting BG levels and for assessing the risk of the onset of hypoglycemia in the near future. The invention is based on two predetermined bio-mathematical routines: a network model of BG fluctuations and a BG profile for assessment of the risk of hypoglycemia.
Owner:UNIV OF VIRGINIA ALUMNI PATENTS FOUND

Surface coating for chamber components used in plasma systems

Disclosed herein are surface coatings for plasma components that have the benefit of being robust against chemical and plasma physical attack in aggressive (e.g., fluorine-based) plasma environments. The coatings also provide low plasma surface recombination rates for active oxygen, nitrogen, fluorine, and hydrogen species when compared with other known surface treatments. The coatings can be applied to any plasma system component not requiring etching or plasma cleaning including but not limited to materials like quartz, aluminum, or anodized aluminum. Additionally, the efficiency of the system is increased by applying a non-reactive coating to system components thereby increasing the flow of excited plasma species to the plasma chamber of the system.
Owner:ENTEGRIS INC

Plasma enhanced atomic layer deposition system and method

A method for depositing a film on a substrate using a plasma enhanced atomic layer deposition (PEALD) process includes disposing the substrate in a process chamber configured to facilitate the PEALD process, introducing a first process material within the process chamber, and introducing a second process material within the process chamber. A first level of electromagnetic power is coupled to the process chamber to generate a plasma that releases contaminants from at least one of a process chamber component or the substrate, and a second level of electromagnetic power higher than the first level is coupled to the process chamber during introduction of the second process material to generate a plasma that facilitates a reduction reaction between the first and second process materials at a surface of the substrate.
Owner:TOKYO ELECTRON LTD

Medical device with porous surface containing bioerodable bioactive composites and related methods

InactiveUS20050119723A1Reduced responseImproving device-tissue interfaceStentsLiquid surface applicatorsActive agentNanoparticle
An implantable medical device includes a porous surface with a composite material located within the pores that includes a bioerodable material in combination with a bioactive agent. The composite material is adapted to erode upon exposure to the body of a patient, thus releasing the bioactive agent into the patient, whereas the porous surface remains on the device. In one embodiment, the composite material includes micro- or nano-particles that are deposited within the pores. In a further embodiment, the porous surface is an electrolessly electrochemically deposited material. Certain tie layer and other surface modification aspects are described to enhance various aspects of the bioactive composite surface. The bioactive composite surface is of particular benefit when provided on an endolumenal stent assembly in a manner adapted to elute anti-restenosis or anti-thrombosis agents or combinations thereof.
Owner:MEDLOGICS DEVICE CORP

Cryotreatment device and method

Devices and methods for cooling vessel walls to inhibit restenosis in conjunction with medical procedures such as coronary artery angioplasty. Stenosed vessel walls can be cooled prior to angioplasty, after angioplasty, or both. The invention is believed to inhibit restenosis through cooling to a temperature near freezing, preferably without causing substantial vessel wall cell death. One catheter device includes a distal tube region having coolant delivery holes radially and longitudinally distributed along the distal region. In some devices, holes spray coolant directly onto the vessel walls, with the coolant absorbed into the blood stream. In other embodiments, a balloon or envelope is interposed between the coolant and the vessel walls and the coolant returned out of the catheter through a coolant return lumen. Some direct spray devices include an occlusion device to restrict blood flow past the region being cooled. Pressure, temperature, and ultrasonic probes are included in some cooling catheters. Pressure control valves are included in some devices to regulate balloon interior pressure within acceptable limits. In applications using liquid carbon dioxide as coolant, the balloon interior pressure can be maintained above the triple point of carbon dioxide to inhibit dry ice formation. Some cooling catheters are coiled perfusion catheters supporting longer cooling periods by allowing perfusing blood flow simultaneously with vessel wall cooling. One coiled catheter is biased to assume a coiled shape when unconstrained and can be introduced into the body in a relatively straight shape, having a stiffening wire inserted through the coil strands.
Owner:BOSTON SCI SCIMED INC

Parasympathetic pacing therapy during and following a medical procedure, clinical trauma or pathology

ActiveUS20060206155A1Increase parasympathetic toneReduced responseSpinal electrodesHeart stimulatorsParasympathetic ganglionPathology diagnosis
A treatment method is provided, including identifying a subject as one who is selected to undergo an interventional medical procedure, and, in response to the identifying, reducing a likelihood of a potential adverse effect of the procedure by applying an electrical current to a parasympathetic site of the subject selected from the group consisting of: a vagus nerve of the subject, an epicardial fat pad of the subject, a pulmonary vein of the subject, a carotid artery of the subject, a carotid sinus of the subject, a coronary sinus of the subject, a vena cava vein of the subject, a jugular vein of the subject, a right ventricle of the subject, a parasympathetic ganglion of the subject, and a parasympathetic nerve of the subject.
Owner:MEDTRONIC INC

UsiRNA Complexes

This disclosure provides double-stranded RNA complexes having one or more hydroxymethyl substituted nucleomonomer(s) in the passenger strand (or sense strand) of an RNA complex. RNA complexes of the disclosure may be useful for therapeutic applications, diagnostic applications or research applications. RNA complexes include short interfering RNA complexes (siRNA) capable of modulating gene expression comprising an antisense strand and a continuous or a discontinuous passenger strand (“sense strand”). Further, one or more hydroxymethyl substituted nucleomonomer(s) of this disclosure may be positioned at the 3′-end, at the 5′-end, at both the 3′-end and 5′end.
Owner:ARCTURUS THERAPEUTICS

Reaction apparatus for producing silicon

A silicon production reactor comprising a reaction vessel and heating means, said reaction vessel comprising a vertically extending wall and a space surrounded by the wall, said heating means being capable of heating at least a part, including lower end portion, of the wall's surface facing the space to a temperature of not lower than the melting point of silicon, said silicon production reactor being adapted to flow raw gas for silicon deposition from an upper part of the space of the reaction vessel toward a lower part thereof, characterized in that the space of the reaction vessel is of slit form in cross-sectional view. This silicon production reactor is capable of attaining improvement with respect to problems encountered at apparatus scaleup, such as decrease of reactivity of raw gas and generation of by-products, thereby accomplishing a striking enhancement of production efficiency.
Owner:TOKUYAMA CORP

Sulfonated block copolymers, method for making same, and various uses for such block copolymers

The present invention is a, solid block copolymer comprising at least two polymer end blocks A and at least one polymer interior block B wherein each A block is a polymer block resistant to sulfonation and each B block is a polymer block susceptible to sulfonation, and wherein said A and B blocks do not contain any significant levels of olefinic unsaturation. Preferably, each A block comprising one or more segments selected from polymerized (i) para-substituted styrene monomers, (ii) ethylene, (iii) alpha olefins of 3 to 18 carbon atoms; (iv) hydrogenated 1,3-cyclodiene monomers, (v) hydrogenated monomers of conjugated dienes having a vinyl content less than 35 mol percent prior to hydrogenation, (vi) acrylic esters, (vii) methacrylic esters, and (viii) mixtures thereof; and each B block comprising segments of one or more polymerized vinyl aromatic monomers selected from (i) unsubstituted styrene monomers, (ii) ortho-substituted styrene monomers, (iii) meta-substituted styrene monomers, (iv) alpha-methylstyrene, (v) 1,1-diphenylethylene, (vi) 1,2-diphenylethylene and (vii) mixtures thereof. Also claimed are processes for making such block copolymers, and the various end uses and applications for such block copolymers.
Owner:KRATON POLYMERS US LLC

Multimode communication system

Multimode, multi-function, multiple modulator-demodulator (modem) system containing a fingerprint sensor, detection, identification, authentication, and processing device for one or multiple fingerprint information to activate one or multiple modulators for signal transmission and generation of authentication information signals. A location information receiver and a processor device for processing and combining the location information and fingerprint information activated signals with one or more additional user generated signals. Processed, combined signals are provided for filtering and / or spread spectrum encoding and / or cross-correlating and connection to one or more modulators and transmitters.
Owner:FEHER KAMILO

Method for producing melt-infiltrated ceramic composites using formed supports

A method for producing shaped articles of ceramic composites provides a high degree of dimensional tolerance to these articles. A fiber preform is disposed on a surface of a stable formed support, a surface of which is formed with a plurality of indentations, such as grooves, slots, or channels. Precursors of ceramic matrix materials are provided to the fiber preform to infiltrate from both sides of the fiber preform. The infiltration is conducted under vacuum at a temperature not much greater than a melting point of the precursors. The melt-infiltrated composite article substantially retains its dimension and shape throughout the fabrication process.
Owner:GENERAL ELECTRIC CO

Implantable biomedical devices including biocompatible polyurethanes

Disclosed are implantable devices that include biocompatible polyurethane materials. In particular, the disclosed polyurethane materials can maintain desired elastomeric characteristics while exhibiting thermoset-like behavior and can exhibit improved characteristics so as to be suitable in load-bearing applications. For example, the disclosed polyurethane materials can be suitable for use in artificial joints, including total joint replacement applications. The disclosed polyurethane materials include biocompatible cross-linking agents as chain extenders, more particularly chain extenders comprising a terminal group capable of side reactions and further comprising an electron withdrawing group immediately adjacent the terminal group. In addition, the reaction materials and conditions can be selected to encourage intermediate levels of cross-linking without the use of traditional cross-linking trifunctional reagents. In addition, the chain extenders can also include substantially inflexible moieties so as to increase the rigidity of the product polyurethanes.
Owner:CLEMSON UNIVERSITY +1

Emergency location transceivers (ELT)

Emergency Location Transceivers (ELT) and communication transceivers (transmitters and receivers) for reception and demodulation of location finder signals, Global Positioning System (GPS) satellite signals and non GPS satellite location finder and other location finder signals. The received location finder signals are demodulated to location finder baseband signals. Baseband signal processors for processing single or a plurality of input signals for providing Orthogonal Frequency Division Multiplex (OFDM) baseband signals, filtered signals, cross-correlated shaped in-phase and quadrature-phase baseband signals and spread spectrum signals. Signal modulators for modulating the processed signals and for providing the modulated signals to the signal transmitter for transmission of the modulated signals. Emergency receiver systems for reception, demodulation and processing of the modulated transmitted signals. Certain emergency receiver embodiments, such as receivers of calls made to emergency call number 911 contain two or more receive antennas for reception and processing of the transmitted modulated signal. In certain embodiments emergency receiver systems have two or more receive antennas operated in a diversity mode, for reception and processing of the transmitted modulated signal.
Owner:FEHER KAMILO

Air based emergency monitor, multimode communication, control and position finder system

Air based emergency monitor, multimode communication, control and position finder system with a receiver having multiple inputs for reception and demodulation of position finder signals to position finder baseband signals. One or more cameras or microphones or data signal generation devices, storage devices, and processors for recording or storing and processing of signals obtained from one or more cameras or microphones or data signal generation devices. A processor for processing input signals and for providing cross-correlated shaped in-phase and quadrature-phase baseband signals. Transceivers for multimode GSM, spread spectrum, CDMA, OFDM, TDMA and other signals. A receiver and demodulator for reception of modulated position finder radio frequency (RF) signals transmitted by a Global Positioning System (GPS) transmitter and a receiver and demodulator for reception of modulated position finder radio frequency (RF) signals transmitted by other than a GPS transmitter for providing the demodulated and receiver processed signal to an emergency unit. An air based position finding, signal monitor, control and emergency multimode communication system for use in one or more units located in or on airplanes, or helicopters, or unmanned vehicles (UV) or balloons or rockets, or missiles, or space shuttles or birds or other air based items with a multimode bit rate agile (BRA) and modulation demodulation (modem) format selectable (MFS) signal modulator.
Owner:FEHER KAMILO

Exhaust aftertreatment system using urea water

An exhaust aftertreatment system comprises an injector for injecting urea water into an exhaust duct, and a denitration catalyst disposed downstream of the injector with respect to a flow of exhaust gas. The exhaust aftertreatment system reduces nitrogen oxides in the exhaust gas by the denitration catalyst while using ammonia produced from the urea water injected from the injector. The urea water is injected along a direction of the flow of the exhaust gas within the exhaust duct, and a porous plate is disposed in multiple stages in a space of the exhaust duct such that droplets of the injected urea water impinge against the porous plate before reaching a wall surface of the exhaust duct. A surface of the porous plate subjected to the impingement of the droplets is arranged to face downstream with respect to the flow of the exhaust gas. Deposition of the urea water is prevented by causing film boiling when the droplets impinge against the porous plate, and the urea water reflected by the porous plate is uniformly dispersed into the exhaust gas. Thus, the urea water is uniformly dispersed into the exhaust gas without increasing a pressure loss of the exhaust gas. The urea water is prevented from depositing on the wall surface and producing a precipitate in the form of a solid.
Owner:HITACHI HIGH-TECH CORP +2

Soft tissue implants and anti-scarring agents

Soft tissue implants (e.g., breast, pectoral, chin, facial, lip, and nasal implants) are used in combination with an anti-scarring agent in order to inhibit scarring that may otherwise occur when the implant is placed within an animal.
Owner:ANGIOTECH INT AG (CH)

Methods, systems, and apparatus for uniform chemical-vapor depositions

Integrated circuits, the key components in thousands of electronic and computer products, are generally built layer by layer on a silicon substrate. One common technique for forming layers is called chemical-vapor deposition (CVD.) Conventional CVD systems not only form layers that have non-uniform thickness, but also have large chambers that make the CVD process wasteful and slow. Accordingly, the inventor devised new CVD systems, methods, and apparatuses. One exemplary CVD system includes an outer chamber, a substrate holder, and a unique gas-distribution fixture. The fixture includes a gas-distribution surface having holes for dispensing a gas and a gas-confinement member that engages or cooperates with the substrate holder to form an inner chamber within the outer chamber. The inner chamber has a smaller volume than the outer chamber, which not only facilitates depositions of more uniform thickness, but also saves gas and speeds up the deposition process.
Owner:MICRON TECH INC

Monitoring, preventing, and treating rejection of transplanted organs

An implantable system control unit (SCU) includes means for measuring tissue impedance or other condition to determine allograft health, in order to predict or detect allograft rejection. The SCU also includes at least two electrodes coupled to means for delivering electrical stimulation to a patient within whom the device is implanted, and may also include a reservoir for holding one or more drugs and a driver means for delivering the drug(s) to the patient. In certain embodiments, the system is capable of open- and closed-loop operation. In closed-loop operation, at least one SCU includes a sensor, and the sensed condition is used to adjust stimulation parameters. Alternatively, this sensory “SCU” sounds an alarm, communicates an alarm to an external device, and / or is responsive to queries regarding sensed information, such as tissue impedance.
Owner:BOSTON SCI NEUROMODULATION CORP

Substrate for liquid crystal display and liquid crystal display utilizing the same

It is an object of the invention to provide a substrate for a liquid crystal display having optical transmittance improved without reducing the speed of a response to a tone change and a liquid crystal display utilizing the same. There is provided a drain bus line formed on an array substrate which sandwiches a liquid crystal in combination with an opposite substrate provided in a face-to-face relationship therewith, a TFT connected to the drain bus line, and a pixel electrode which has stripe-shaped electrodes, along with spaces, connected to the TFT and provided in parallel with the drain bus line, stripe-shaped electrodes in the vicinity of the drain bus line having an electrode width formed narrower than the width of internal electrodes located inside the same.
Owner:SHARP KK

Methods and kits for proximity probing

The present invention relates to sensitive, rapid and convenient assays for detection and / or quantification of one or several analyte(s) in solution using so called proximity probes. The proximity probes comprise a binding moiety and a nucleic acid. The nucleic acid from one proximity probe is only capable of interaction with the nucleic acid from the other proximity probe when these are in close proximity, i.e. have bound to the analytes for which they are specific. The present invention relates to methods and kits for proximity probing and are performed in solution without the need of a solid phase.
Owner:OLINK PROTEOMICS AB

Medical diagnostic and communication system

Cardiac stimulation device and wireless communication system, without magnetic detection or magnetic control of the heart pacemaker parameters, having leads for carrying stimulating pulses to and or from one or more electrodes located in a heart and a pulse generator configured to generate stimulation pulses. In certain embodiments and environments the heart pacemaker could operate in an emergency room, even during Magnetic Resonance Imaging (MRI) diagnostic studies. A processor for connection of the stimulating pulses to and / or from one or more spread spectrum transmitter-receiver (T / R) circuits and / or from a signal processing network for receiving said stimulation pulses and for providing cross-correlated in-phase and quadrature-phase baseband signals. One or more modulators and demodulators for transmission and / or reception of one or more spread spectrum and / or cross-correlated signals.
Owner:FEHER KAMILO

Concrete mixtures incorporating high carbon pozzolans and foam admixtures

Concrete mixtures are manufactured to include high carbon pozzolans and a foam admixture (for air entrainment). The foam bubbles in the foam admixture are stabilized in the presence of the high carbon fly ash by a fluorochemical surfactant. The fluorochemical surfactant preferably comprises an oligomer comprising hydrophilic nonionic monomers and hydrophilic anionic monomers. The high carbon pozzolans can preferably have an LOI greater than between about 1.5% and about 6.0%, without substantially affecting the durability of the foam bubbles in the concrete mixture.
Owner:JACK B PARSON

Cryotreatment device and method

Devices and methods for cooling vessel walls to inhibit restenosis in conjunction with medical procedures such as coronary artery angioplasty. Stenosed vessel walls can be cooled prior to angioplasty, after angioplasty, or both. The invention is believed to inhibit restenosis through cooling to a temperature near freezing, preferably without causing substantial vessel wall cell death. One catheter device includes a distal tube region having coolant delivery holes radially and longitudinally distributed along the distal region. In some devices, holes spray coolant directly onto the vessel walls, with the coolant absorbed into the blood stream. In other embodiments, a balloon or envelope is interposed between the coolant and the vessel walls and the coolant returned out of the catheter through a coolant return lumen. Some direct spray devices include an occlusion device to restrict blood now past the region being cooled. Pressure, temperature, and ultrasonic probes are included in some cooling catheters. Pressure control valves are included in some devices to regulate balloon interior pressure within acceptable limits. In applications using liquid carbon dioxide as coolant, the balloon interior pressure can be maintained above the triple point of carbon dioxide to inhibit dry ice formation. Some cooling catheters are coiled perfusion catheters supporting longer cooling periods by allowing perfusing blood flow simultaneously with vessel wall cooling. One coiled catheter is biased to assume a coiled shape when unconstrained and can be introduced into the body in a relatively straight shape, having a stiffeninig wire inserted through the coil strands.
Owner:BOSTON SCI SCIMED INC

Selective data downloading and presentation based on user interaction

Some embodiments of the invention are directed to, among other things, systems, computer readable media, methods and any other means for using a handheld device to present information to a user. The handheld device and server(s) can be configured to differentiate among inexpensive and expensive information. For example, the handheld device can be configured to present media listings that represent media stored on the server(s). Each media listing can include text (inexpensive information) and thumbnails (expensive information). While the user scrolls through the media listings, the new listings can only include text. Once the scrolling stops, the missing thumbnails can be downloaded and integrated into their corresponding listings. In response to a listing being selected, the corresponding media file can be downloaded and / or played back to the user by the handheld device.
Owner:APPLE INC

Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells

A chimeric LL2 monoclonal antibody is described in which the complementarity determining regions (CDRs) of the light and heavy chains of the murine LL2 anti-B-lymphoma, anti-leukemia cell monoclona lantibody has been recombinantly joined to the human kappa and IgG1 constant region domains, respectively, which retains the immunospecificity and B-cell lymphoma and leukemia cell internalization capacity of the parental murine LL2 monoclonal antibody, and which has the potential of exhibiting reduced human anti-mouse antibody production activity. A humanized LL2 monoclonal antibody is described in which the CDRs of the light and heavy chains have been recombinantly joined to a framework sequence of human light and heavy chains variable regions, respectively, and subsequently linked to human kappa and IgG1 constant region domains, respectively, which retains the immunospecificity and B-lymphoma and leukemia cell internalization capacities of the parental murine and chimeric LL2 monoclonal antibodies, and which has the potential for exhibiting reduced human anti-mouse antibody production activity. Vectors for producing recombinant chimeric and humanized chimeric monoclonal antibodies are provided. Isolated DNAs encoding the amino acid sequences of the LL2 variable light and heavy chain and CDR framework regions are described. Conjugates of chimeric and humanized chimeric LL2 antibodies with cytotoxic agents or labels find use in therapy and diagnosis of B-cell lymphomas and leukemias.
Owner:IMMUNOMEDICS INC

Biocompatible hemostatic, antiblocking, healing-promoting and surgical wound-closing modified starch material

The invention relates to a modified starch material for biocompatible hemostasis, biocompatible anti-adhesion, tissue healing promotion, absorbable surgery sealing and tissue adhesion. The invention applies biocompatible modified starch to animal tissues, wherein the modified starch material has the molecular weight of more than 15,000 daltons, and the particle diameter of between 1 and 1,000 mu m. The modified starch hemostatic material has stypticity, reduces hemorrhage, blood oozing and tissue fluid oozing of wounds, maintains relative moistening or drying of wound surfaces or the wounds, inhibits bacterium growth and inflammation reaction, and contributes to locally diminish inflammation of the wounds and relieve pain of patients. Moreover, the modified starch material can wash local parts after operation is over and remove redundant modified starch which does not participate in hemostasis, and can easily remove haemostatic under the condition of debridement treatment after self-help and first-aid treatment of war wounds; and hemostatic materials with a small amount of modified starch can be absorbed by the body, so that the pain of tearing of gauzes and bandages on people is avoided.
Owner:BEIJING UNIVERSAL LIKANG TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products